Cargando…
Urate‐lowering therapy alleviates atherosclerosis inflammatory response factors and neointimal lesions in a mouse model of induced carotid atherosclerosis
Hyperuricemia (HU) is a cause of gout. Clinical studies show a link between HU and cardiovascular disease. However, the role of soluble serum urate (SU) on atherosclerosis development remains elusive. We aimed to use a new HU mouse model [Uricase/Uox knockout (KO)] to further investigate the relatio...
Autores principales: | Lu, Jie, Sun, Mingshu, Wu, Xinjiang, Yuan, Xuan, Liu, Zhen, Qu, Xiaojie, Ji, Xiaopeng, Merriman, Tony R., Li, Changgui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6849826/ https://www.ncbi.nlm.nih.gov/pubmed/30690853 http://dx.doi.org/10.1111/febs.14768 |
Ejemplares similares
-
Serum Urate Levels and Ultrasound Characteristics of Carotid Atherosclerosis across Obesity Phenotypes
por: Efremova, Daniela, et al.
Publicado: (2023) -
3,4-dimethoxychalcone induces autophagy and reduces neointimal hyperplasia and aortic lesions in mouse models of atherosclerosis
por: Cerrato, Giulia, et al.
Publicado: (2023) -
Baseline urate level and renal function predict outcomes of urate-lowering therapy using low doses of febuxostat and benzbromarone: a prospective, randomized controlled study in a Chinese primary gout cohort
por: Liang, Nan, et al.
Publicado: (2019) -
Cyclooxygenase inhibitors repress vascular hyaluronan-synthesis in murine atherosclerosis and neointimal thickening
por: Marzoll, Andrea, et al.
Publicado: (2009) -
Carotid Atherosclerosis, Ultrasound and Lipoproteins
por: Iannuzzi, Arcangelo, et al.
Publicado: (2021)